Alan P Hudson

Author PubWeight™ 49.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum 2009 1.77
2 Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin North Am 2009 1.35
3 Differential expression of three Chlamydia trachomatis hsp60-encoding genes in active vs. persistent infections. Microb Pathog 2004 1.27
4 Transcriptome profiling of Saccharomyces cerevisiae during a transition from fermentative to glycerol-based respiratory growth reveals extensive metabolic and structural remodeling. Mol Genet Genomics 2006 1.26
5 Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease. J Alzheimers Dis 2008 1.21
6 Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection. Microbes Infect 2002 1.19
7 Detection of nucleotide variability in rpoB in both rifampin-sensitive and rifampin-resistant strains of Chlamydia trachomatis. Antimicrob Agents Chemother 2003 1.17
8 Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice. Immunology 2005 1.11
9 Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae. Nanomedicine 2013 1.09
10 Persistent Chlamydiae and chronic arthritis. Arthritis Res 2001 1.05
11 Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain. FEMS Immunol Med Microbiol 2006 1.03
12 Cytokine and chemokine mRNA produced in synovial tissue chronically infected with Chlamydia trachomatis and C. pneumoniae. J Rheumatol 2002 1.02
13 Soluble egg antigens from Schistosoma mansoni induce angiogenesis-related processes by up-regulating vascular endothelial growth factor in human endothelial cells. J Infect Dis 2002 1.01
14 Dendrimer-enabled modulation of gene expression in Chlamydia trachomatis. Mol Pharm 2012 0.99
15 Expression of matrix metalloproteinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice. Immunology 2004 0.94
16 Infectious agents and multiple sclerosis--are Chlamydia pneumoniae and human herpes virus 6 involved? J Neuroimmunol 2003 0.93
17 Molecular biology of infectious agents in chronic arthritis. Rheum Dis Clin North Am 2009 0.93
18 New insights into Chlamydia and arthritis. Promise of a cure? Ann Rheum Dis 2013 0.93
19 Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest Ophthalmol Vis Sci 2004 0.92
20 Dendrimer-enabled transformation of Chlamydia trachomatis. Microb Pathog 2013 0.91
21 The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype. Microb Pathog 2005 0.91
22 Rsf1p, a protein required for respiratory growth of Saccharomyces cerevisiae. Curr Genet 2003 0.90
23 The evolving story of Chlamydia-induced reactive arthritis. Curr Opin Rheumatol 2010 0.90
24 The molecular genetic basis of mitochondrial malfunction in bladder tissue following outlet obstruction. J Urol 2004 0.90
25 Patients with Chlamydia-associated arthritis have ocular (trachoma), not genital, serovars of C. trachomatis in synovial tissue. Microb Pathog 2009 0.89
26 The transcript profile of persistent Chlamydophila (Chlamydia) pneumoniae in vitro depends on the means by which persistence is induced. FEMS Microbiol Lett 2008 0.89
27 Spermatogenetic expression of RNA-binding motif protein 7, a protein that interacts with splicing factors. J Androl 2003 0.85
28 Autoimmune Th2-mediated dacryoadenitis in MRL/MpJ mice becomes Th1-mediated in IL-4 deficient MRL/MpJ mice. Invest Ophthalmol Vis Sci 2007 0.84
29 Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice. Invest Ophthalmol Vis Sci 2004 0.84
30 Chlamydophila (Chlamydia) pneumoniae infection of human astrocytes and microglia in culture displays an active, rather than a persistent, phenotype. Am J Med Sci 2006 0.84
31 Chlamydia and chronic arthritis. Ann Med 2011 0.84
32 Human herpesvirus 6 and Chlamydia pneumoniae as etiologic agents in multiple sclerosis - a critical review. Microbes Infect 2002 0.83
33 Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain. Int J Med Microbiol 2008 0.83
34 Up-regulation of a cellular protein at the translational level by a retrovirus. Proc Natl Acad Sci U S A 2008 0.83
35 Molecular mimicry and horror autotoxicus: do chlamydial infections elicit autoimmunity? Expert Rev Mol Med 2006 0.82
36 Detection of DNA from a range of bacterial species in the knee joints of dogs with inflammatory knee arthritis and associated degenerative anterior cruciate ligament rupture. Microb Pathog 2007 0.82
37 Rsf1p is required for an efficient metabolic shift from fermentative to glycerol-based respiratory growth in S. cerevisiae. Yeast 2009 0.82
38 Etiology and pathogenesis of late-onset Alzheimer's disease. Curr Allergy Asthma Rep 2014 0.81
39 Regulation of Sam68 activity by small heat shock protein 22. J Cell Biochem 2006 0.80
40 Chlamydia trachomatis is present and metabolically active during the remitting phase in synovial tissues from patients with chronic Chlamydia-induced reactive arthritis. Am J Med Sci 2013 0.80
41 The YJR127C/ZMS1 gene product is involved in glycerol-based respiratory growth of the yeast Saccharomyces cerevisiae. Curr Genet 2005 0.80
42 Fate of Chlamydophila pneumoniae in human monocyte-derived dendritic cells: long lasting infection. Microb Pathog 2006 0.80
43 No correlation between giant cell arteritis and Chlamydia pneumoniae infection: investigation of 189 patients by standard and improved PCR methods. J Clin Microbiol 2009 0.78
44 The pathogenic role of Chlamydia in spondyloarthritis. Curr Opin Rheumatol 2010 0.78
45 The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis. Int J Clin Rheumtol 2012 0.78
46 PAMAM dendrimer-azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infections. Nanomedicine 2011 0.78
47 Apolipoprotein E4 enhances attachment of Chlamydophila (Chlamydia) pneumoniae elementary bodies to host cells. Microb Pathog 2007 0.77
48 Attack rate of Chlamydia-induced reactive arthritis and effect of the CCR5-Delta-32 mutation: a prospective analysis. J Rheumatol 2013 0.76
49 Ultrastructural Analysis of Chlamydia Pneumoniae in the Alzheimer's Brain. Pathogenesis (Amst) 1999 0.76
50 Seasonal variation in detection of bacterial DNA in arthritic stifle joints of dogs with cranial cruciate ligament rupture using PCR amplification of the 16S rRNA gene. Vet Microbiol 2009 0.76
51 Transmission of Chlamydophila pneumoniae from dendritic cells to macrophages does not require cell-to-cell contact in vitro. J Microbiol Methods 2007 0.76
52 Functional CCR5 receptor protects patients with arthritis from high synovial burden of infecting Chlamydia trachomatis. Am J Med Sci 2010 0.75
53 Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight? Int J Clin Rheumtol 2011 0.75
54 Lack of evidence for bacterial infections in skin in patients with systemic sclerosis. Am J Med Sci 2009 0.75
55 Cloning of COX4 cDNA from the NZ white rabbit and expression of this gene in bladder smooth muscle following partial outlet obstruction. World J Urol 2002 0.75